Angelalign (06699) has issued a positive profit alert, projecting a net profit of approximately $24.0 million to $25.4 million for the first half of 2026, representing a year-on-year increase of 69.0% to 78.9%.
The group expects to record total revenue of around $229 million to $231 million for the period, up 41.9% to 43.1% year-on-year. The total number of clear aligner cases is estimated at approximately 316,600, a 40.2% increase compared to the same period last year. Of these, case volumes in global markets (excluding Mainland China) grew 43.3% to about 168,000, while cases in Mainland China rose approximately 36.8% to around 148,600.
Reasons behind the improved performance
The board attributes the anticipated improvement in the group's results to several key factors. Firstly, doctors across global and domestic markets are increasingly shifting toward clear aligner systems with proven clinical efficacy, from which Angelalign continues to benefit. Secondly, the professional brand and international direct sales and service networks, which were a focus of investment in prior years, are beginning to show operating leverage, thereby enhancing profitability. Finally, the company's open management culture, which integrates multinational technical talent and clinical knowledge, has accelerated product and service innovation.
Comments